Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F7BR5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,085
Award facts
- Contract value 100% obligated
- $12,085.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,085.46 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg dose in 2 pen/ml configuration. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of December 16, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad portfolio of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's substantial IDC with DLA reflects its capability to fulfill diverse federal medical supply requirements through open competition. This particular delivery order for Cosentyx, a specialty immunosuppressant medication used in treating conditions such as psoriasis and rheumatoid arthritis, exemplifies the company's role in providing brand-name medications to support military personnel and veteran healthcare needs across the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F7BR5?
SPE2DR26F7BR5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F7BR5 worth?
The government has obligated $12,085 on SPE2DR26F7BR5.
Is contract SPE2DR26F7BR5 an order under another contract?
Yes. SPE2DR26F7BR5 is a delivery order under SPE2DR25D3504, an indefinite delivery contract.
Was contract SPE2DR26F7BR5 competed?
The extent of competition for SPE2DR26F7BR5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award